Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company's core product, sac-TMT (Lukangshatuo monoclonal antibody), is showing strong commercialization progress, contributing significantly to sales revenue [6][7] - The company has adjusted its revenue forecasts for 2025 to 2027, expecting revenues of 17.53 billion, 28.67 billion, and 48.64 billion respectively, reflecting a positive outlook on sales growth [6] - The company is preparing for multiple data disclosures at the ESMO conference in 2025, which could serve as potential catalysts for growth [8] Financial Performance Summary - In H1 2025, the company reported revenue of 950 million, a year-on-year decrease of 31.3%, primarily due to high milestone payments recognized in the same period of 2024 [6] - The net loss attributable to the parent company was 145 million, with an adjusted net loss of 69 million [6] - The sales revenue from pharmaceuticals reached 309.8 million, with sac-TMT accounting for 97.6% of total pharmaceutical sales [7] Revenue and Profit Forecasts - The company expects a revenue decline of 9.3% in 2025, followed by significant growth of 63.5% in 2026 and 69.7% in 2027 [9] - The projected net profit for 2027 is expected to reach 1,049 million, indicating a turnaround from losses in previous years [9] Valuation Metrics - The price-to-sales (P/S) ratios for 2025, 2026, and 2027 are projected to be 56.7, 34.6, and 20.4 respectively [9] - The price-to-book (P/B) ratios for the same years are expected to be 37.3, 40.7, and 28.3 [9]

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company achieved a revenue of 9.953 billion CNY, representing a year-over-year increase of 16.1%, and a net profit of 2.339 billion CNY, up 56.0% year-over-year, with a gross margin improvement of 3.6 percentage points to 42.7% [1][2] - The total number of projects reached a new high of 864, with 86 new projects added in the first half of 2025, indicating strong professional capabilities [2] - The company has a substantial order backlog of 20.3 billion USD, including 11.4 billion USD in service orders and 9 billion USD in potential milestone payments, supporting future revenue growth [3] Summary by Sections Financial Performance - Revenue for 2025 is projected at 21.46 billion CNY, with a growth rate of 14.9% [5] - The net profit forecast for 2025 is 4.273 billion CNY, reflecting a growth rate of 27.3% [5] - The company expects to complete 25 PPQs in 2025, significantly up from 16 in 2024, with a 98% success rate [3] Market and Regional Performance - North America remains the primary revenue driver with a year-over-year growth of 20.1%, while Europe and China showed stable performance with growth of 5.7% and a decline of 8.5%, respectively [2] - Other regions experienced rapid revenue growth of 136%, indicating increased market penetration in emerging markets [2] Valuation and Earnings Forecast - The revised net profit forecasts for 2025-2027 are 4.273 billion CNY, 4.668 billion CNY, and 5.348 billion CNY, respectively, with corresponding P/E ratios of 27, 25, and 22 [3][5]

Investment Rating - The report maintains a "Buy" rating for 卓越教育集团 (Excellence Education Group) [5] Core Views - The company achieved a revenue of 920 million CNY in H1 2025, representing a year-on-year increase of 188.9%, and a net profit of 150 million CNY, up 177.4% year-on-year [1] - The rapid growth in quality education services and significant results from AI empowerment are highlighted as key drivers of revenue growth [1][2] - The company is focusing on deepening its market presence in the Greater Bay Area, particularly in Guangzhou, Shenzhen, and Foshan, leveraging local courses and brand influence [3] Revenue and Profitability - In H1 2025, the revenue breakdown by business segments shows quality education at 723 million CNY (up 513.1%), full-time review at 101 million CNY (down 18.3%), and tutoring projects at 89 million CNY (up 17.6%) [1] - The gross margin for H1 2025 was 45.0%, a slight increase of 0.1 percentage points year-on-year, with all business segments showing improved margins [2] - The net profit margin for H1 2025 was 16.5%, down 0.7 percentage points year-on-year, primarily due to increased investments in regional expansion, research, and AI [2] Future Outlook - The company plans to continue enhancing AI applications in education, with upcoming features like "personalized question recommendations" and "AI study companions" to improve service experience [3] - A three-year dividend plan has been announced, with a commitment to gradually increase the payout ratio to 50%, 60%, and 70% from 2024 to 2026, reflecting management's confidence in future growth [3] Financial Projections - The projected net profits for 2025, 2026, and 2027 are 333 million CNY, 423 million CNY, and 502 million CNY respectively, with corresponding P/E ratios of 12x, 10x, and 8x [3][4]

Investment Rating - The investment rating for Miniso (9896.HK) is not explicitly stated in the provided documents, but the report indicates a positive outlook based on performance metrics and growth expectations. Core Insights - Miniso's H1 2025 performance exceeded expectations with revenue of CNY 9.393 billion, a year-on-year increase of 21.1%, and adjusted net profit of CNY 1.279 billion, up 3% [1] - In Q2 2025, the company achieved revenue of CNY 4.966 billion, a 23.1% increase, surpassing the previous guidance of 18-21% [1] - The adjusted operating profit for Q2 2025 was CNY 0.852 billion, reflecting an 8.5% increase, with an adjusted operating profit margin of 17.2% [1] Summary by Sections Financial Performance - For H1 2025, Miniso reported revenue of CNY 9.393 billion, with an adjusted operating profit of CNY 1.587 billion and an adjusted net profit of CNY 1.279 billion [1] - Q2 2025 revenue reached CNY 4.966 billion, with adjusted net profit at CNY 0.692 billion, marking a 10.6% increase year-on-year [1] - The adjusted net profit margin for Q2 2025 was 13.9%, down 1.6 percentage points year-on-year [1] Store Performance - Significant improvement in same-store sales was noted, with the Miniso brand achieving flat same-store sales, while revenue from the Miniso brand increased by 19.5% to CNY 4.563 billion in Q2 2025 [2] - The number of Miniso stores reached 7,612 by June 30, 2025, with 4,305 in mainland China and 3,307 overseas [2] Cost and Profitability - The gross margin for Q2 2025 was 44.3%, an increase of 0.4 percentage points year-on-year, attributed to higher overseas revenue contribution and improved margins from the Top Toy brand [3] - Sales and distribution expenses rose by 40.4% due to investments in direct stores and strategic overseas market expansion [3] Future Projections - Revenue projections for 2025-2027 are CNY 21.5 billion, CNY 25.5 billion, and CNY 29.6 billion, representing growth rates of 27%, 19%, and 16% respectively [4] - Expected net profit for 2025 is CNY 2.312 billion, reflecting a 12% decrease, followed by increases of 32% and 23% in subsequent years [4]

Investment Rating - The report maintains an "Outperform" rating for CK Infrastructure Holdings [2][11]. Core Views - The performance in the first half of 2025 was in line with expectations, with a net profit attributable to shareholders of HK$4.348 billion, reflecting a 1% year-on-year increase. The company declared an interim dividend of HK$0.73 per share, a 1.4% increase from the previous year [3][9]. - The UK portfolio showed strong performance, contributing HK$2.223 billion, a 19% year-on-year increase, driven by various operational strengths. In contrast, the Australian and Canadian sectors underperformed [4][10]. - The company is undergoing a dynamic portfolio rebalancing, including the sale of UK Rails, which is expected to significantly reduce its net debt ratio [5][11]. Summary by Sections Financial Performance - For the first half of 2025, CK Infrastructure achieved a net profit of HK$4.348 billion, with cash on hand at HK$4.7 billion and a net debt to net total capital ratio of 10.6% [3][9]. - Revenue projections for 2025-2027 are estimated at HK$7.665 billion, HK$7.733 billion, and HK$7.683 billion respectively, with net profits expected to be HK$9.332 billion, HK$9.580 billion, and HK$9.688 billion [2][8]. Regional Performance - The UK infrastructure portfolio's contribution was HK$2.223 billion, up 19% year-on-year, while the Australian portfolio contributed HK$793 million, down 8% year-on-year [4][10]. - The Canadian portfolio contributed HK$275 million, a decrease of 9% year-on-year, primarily due to lower generation and prices [10]. Investment Strategy - The company plans to continue advancing various investment projects, including smart grids and renewable energy integration, while the sale of UK Rails is expected to enhance financial flexibility [5][11]. - The target price is maintained at HK$61.37, reflecting a positive outlook for the company's future performance [2][11].

Investment Rating - The investment rating for the company is "Outperform the Market" [5][18]. Core Viewpoints - The company's core product, sac-TMT, has received domestic approval and is rapidly advancing through global Phase 3 clinical trials. The first two indications (TNBC 3L and EGFRm NSCLC 3L) are expected to be approved by the end of 2024 and early 2025, respectively, making it the first TROP2 ADC approved for lung cancer indications [1][14]. - The company has a robust pipeline in the ADC field, with multiple candidates in clinical trials, including SKB571/MK-2750, which targets LC and CRC, and several potential first-in-class ADCs [2][14]. - The commercial sales of sac-TMT are expected to ramp up significantly, especially with its anticipated inclusion in the medical insurance negotiations this year, which could lead to rapid market penetration [2][8]. Financial Performance and Forecast - The company's revenue for the first half of 2025 is projected to be 950 million yuan, with commercial sales contributing approximately 310 million yuan, primarily from sac-TMT. The company reported a loss of 145 million yuan in the same period, compared to a profit of 310 million yuan in the previous year [2][8]. - Revenue forecasts for 2025-2027 are 1.941 billion yuan, 2.928 billion yuan, and 4.767 billion yuan, respectively, with net profits expected to be -721 million yuan, -302 million yuan, and 475 million yuan [3][18]. - The company’s cash and financial assets totaled 4.53 billion yuan as of June 30 [2][8].

Investment Rating - The report maintains a "Buy" rating for Tencent Holdings with a target price not specified [7]. Core Insights - Tencent's overall performance in Q2 2025 shows strong revenue and profit growth, with AI capabilities contributing significantly [1]. - Revenue increased by 15% year-on-year, while gross profit rose by 22%. Non-IFRS operating profit grew by 18%, and Non-IFRS net profit increased by 10%, all exceeding Bloomberg consensus expectations [1]. - The company emphasizes the substantial contributions of AI to advertising effectiveness and long-standing games, with various AI features launched within WeChat [2]. - The gaming segment saw a 22% increase in revenue, driven by both domestic and international markets, with notable titles contributing to this growth [3]. - Marketing services revenue grew by 20%, with significant increases in video account and search advertising, supported by AI enhancements [4]. - Financial technology and enterprise services also showed a 10% growth in revenue, with improved gross margins [5]. Summary by Sections Overall Performance - Q2 2025 revenue and profit growth were strong, with revenue exceeding Bloomberg expectations primarily from gaming and advertising [1]. AI Contributions - AI applications have been integrated into various services, enhancing advertising performance and user engagement [2]. Gaming Revenue - Network gaming revenue increased by 22%, with both domestic and international markets performing well [3]. Marketing Services - Marketing services revenue exceeded expectations, driven by AI improvements in advertising effectiveness [4]. Financial Technology and Enterprise Services - Financial technology and enterprise services revenue grew by 10%, with enhanced profitability [5].

Investment Rating - The report maintains a "Buy" rating for Greentown Service (02869) [3][8] Core Views - Greentown Service has demonstrated strong performance in the first half of 2025, with revenue of 9.29 billion yuan, a year-on-year increase of 6.1%, and core operating profit rising by 25.3%, exceeding market expectations [8] - The company is focusing on quality improvement and operational efficiency, which has led to an increase in gross margin and net profit margin [8] - The company is expected to continue its stable expansion through third-party services, with a strong focus on the Yangtze River Delta region [8] Financial Data and Profit Forecast - Revenue projections for Greentown Service are as follows: - 2023: 17,393 million yuan - 2024: 17,893 million yuan - 2025E: 19,377 million yuan - 2026E: 21,270 million yuan - 2027E: 22,938 million yuan - Year-on-year growth rates for revenue are projected at: - 2023: 17.1% - 2024: 2.8% - 2025E: 8.3% - 2026E: 9.8% - 2027E: 7.8% [7][9] - Net profit attributable to the parent company is forecasted as follows: - 2023: 605 million yuan - 2024: 785 million yuan - 2025E: 922 million yuan - 2026E: 1,053 million yuan - 2027E: 1,184 million yuan - Year-on-year growth rates for net profit are projected at: - 2023: 10.6% - 2024: 29.7% - 2025E: 17.4% - 2026E: 14.3% - 2027E: 12.4% [7][9] Operational Highlights - As of the end of the first half of 2025, the managed area reached 536 million square meters, a year-on-year increase of 11.3% [8] - The company has a reserve area of 347 million square meters, down 2.9% year-on-year, due to a strategic withdrawal from risk-prone projects [8] - The satisfaction rate of services is reported at 93 points, an increase of 3 percentage points year-on-year, with a project renewal rate of 96.5%, up 2.4 percentage points [8]

Investment Rating - The investment rating for WuXi AppTec (02268.HK) is "Buy" (maintained) [1] Core Views - The company reported strong performance in H1 2025, with revenue reaching 2.701 billion yuan, a year-on-year increase of 58.88%, and a net profit of 746 million yuan, up 52.74% year-on-year [4] - The total amount of unfulfilled orders reached 1.329 billion USD, representing a year-on-year growth of approximately 57.9%, which provides assurance for the company's future growth [4] - The company has a robust client base, serving 563 clients, including 13 of the top 20 global pharmaceutical companies, which accounted for 32.8% of total revenue in 2024 [4] - The company is positioned as a leading player in the global ADC (Antibody-Drug Conjugate) CDMO (Contract Development and Manufacturing Organization) market, prompting an upward revision of profit forecasts for 2025-2027 [4] Financial Performance Summary - For H1 2025, the company achieved revenue of 2.701 billion yuan, a 58.88% increase year-on-year; net profit was 746 million yuan, up 52.74% year-on-year; adjusted net profit was 801 million yuan, a 50.1% increase [4] - The company expects net profits for 2025-2027 to be 1.612 billion, 2.151 billion, and 2.932 billion yuan respectively, with EPS projected at 1.3, 1.8, and 2.4 yuan [4] - The current stock price corresponds to P/E ratios of 40.3, 30.2, and 22.1 for 2025, 2026, and 2027 respectively [4] Strategic Developments - The company has successfully implemented a strategy of "Empower, Follow, and Win Molecules," resulting in a 34.7% year-on-year increase in the number of projects, totaling 225 [5] - The company is expanding its global production capacity with operational bases in Wuxi, Changzhou, and Shanghai, and is also expanding facilities in Wuxi and Singapore [6] - Revenue from North America, China, Europe, and other regions for H1 2025 was 1.391 billion, 485 million, 605 million, and 221 million yuan respectively, with year-on-year growth rates of 68.9%, 11.4%, 95.0%, and 128.5% [6]

Investment Rating - The report maintains a "Buy" rating for Xiaomi Group [4][7]. Core Insights - The innovative business segment is rapidly developing, with revenue from smart electric vehicles and AI reaching 21.3 billion yuan in Q2 2025, despite an operating loss of 300 million yuan. The Xiaomi YU7 series launched with over 240,000 units locked in within 18 hours, indicating strong demand [2]. - The overseas penetration of the smartphone business is increasing, with Q2 2025 smartphone revenue at 45.5 billion yuan and a gross margin of 11.5%. Global shipments reached 42.4 million units, a year-on-year increase of 0.6%, with a market share of 14.7% [2]. - IoT and lifestyle product revenue reached a record high of 38.7 billion yuan in Q2 2025, growing 44.7% year-on-year, driven by demand for smart appliances and wearable products in mainland China [3]. Financial Projections - The report forecasts adjusted EPS for 2025-2027 to be 1.80, 2.32, and 2.99 yuan, corresponding to P/E ratios of 26.82, 20.88, and 16.19 respectively [4][6]. - Revenue projections for 2025-2027 are 483.38 billion yuan, 595.47 billion yuan, and 726.58 billion yuan, with year-on-year growth rates of 32.11%, 23.19%, and 22.02% [6][13]. - The net profit attributable to the parent company is expected to grow from 40.72 billion yuan in 2025 to 67.37 billion yuan in 2027, with growth rates of 72.11% and 28.87% respectively [6][12]. Market Position - Xiaomi ranks among the top three global smartphone vendors, with significant market share increases in Southeast Asia, Europe, and Africa [2]. - The company is expected to leverage its high-end strategy and overseas expansion to drive steady growth in its smartphone business despite short-term margin pressures [2]. Strategic Outlook - The report expresses optimism regarding Xiaomi's high-end product strategy, the continuous development of AI technology and ecosystem, and the ongoing growth of its automotive business [4].